Equities research analysts at Wedbush reduced their Q2 2025 earnings per share (EPS) estimates for Meritage Homes in a report ...
Hosted on MSN2h
Wedbush Initiates Coverage of Bicara Therapeutics (BCAX) with Outperform RecommendationFintel reports that on February 6, 2025, Wedbush initiated coverage of Bicara Therapeutics (NasdaqGM:BCAX) with a Outperform ...
Adicet Bio (NASDAQ:ACET – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at HC Wainwright in a research note issued on Wednesday,Benzinga reports. A number of other ...
Revenue: Analysts tracked by FactSet expect $187.3 billion in revenue, up from $170.0 billion a year before. The FactSet consensus calls for 8.6% growth in North America revenue to $114.6 billion, 9.7 ...
Palantir trades at valuations such that the stock still looks richly valued even after hyperbolic growth in its business.
In a report released today, Jay McCanless from Wedbush maintained a Hold rating on LGI Homes (LGIH – Research Report), with a price target of ...
In a report released today, Robert Driscoll from Wedbush maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target ...
In many ways, these have been tough days for Tesla. Falling sales. Squeezed profit margins. Proposed changes in US government ...
International Business Machines Corp. (IBM) received a thumbs-up from Wedbush analysts on Wednesday after its strong ...
Key Features of Wedbush’s Automated Locate Service: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback